99 related articles for article (PubMed ID: 3981462)
1. Differential effects of xylamine on extracellular concentrations of norepinephrine and dopamine in rat central nervous system: an in vivo electrochemical study.
Howard-Butcher S; Blaha CD; Lane RF
J Pharmacol Exp Ther; 1985 Apr; 233(1):58-63. PubMed ID: 3981462
[TBL] [Abstract][Full Text] [Related]
2. The actions of xylamine on central noradrenergic neurons.
Dudley MW; Butcher LL; Kammerer RC; Cho AK
J Pharmacol Exp Ther; 1981 Jun; 217(3):834-40. PubMed ID: 7230010
[TBL] [Abstract][Full Text] [Related]
3. The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta.
Cho AK; Ransom RW; Fischer JB; Kammerer RC
J Pharmacol Exp Ther; 1980 Aug; 214(2):324-7. PubMed ID: 7391980
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of [3H]norepinephrine uptake in organ cultured rat superior cervical ganglia by xylamine.
Fischer JB; Cho AK
J Pharmacol Exp Ther; 1982 Jan; 220(1):115-9. PubMed ID: 7053407
[TBL] [Abstract][Full Text] [Related]
5. Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.
Fischer JB; Cho AK
J Pharmacol Exp Ther; 1983 Jun; 225(3):623-9. PubMed ID: 6864523
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
Liang P; Chang SS; Cheng JT
Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine and neural plasticity: the effects of xylamine on experience-induced changes in brain weight, memory, and behavior.
Benloucif S; Bennett EL; Rosenzweig MR
Neurobiol Learn Mem; 1995 Jan; 63(1):33-42. PubMed ID: 7663878
[TBL] [Abstract][Full Text] [Related]
8. A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.
Dudley MW; Siegel BW; Ogden AM; McCarty DR
J Pharmacol Exp Ther; 1988 Oct; 247(1):174-9. PubMed ID: 2459367
[TBL] [Abstract][Full Text] [Related]
9. Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.
Kihara T; Ikeda M
J Pharmacol Exp Ther; 1995 Jan; 272(1):177-83. PubMed ID: 7815331
[TBL] [Abstract][Full Text] [Related]
10. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
Fischer JB; Waggaman LA; Ransom RW; Cho AK
J Pharmacol Exp Ther; 1983 Sep; 226(3):650-5. PubMed ID: 6887005
[TBL] [Abstract][Full Text] [Related]
11. Effects of MF-268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex.
Zhu XD; Cuadra G; Brufani M; Maggi T; Pagella PG; Williams E; Giacobini E
J Neurosci Res; 1996 Jan; 43(1):120-6. PubMed ID: 8838583
[TBL] [Abstract][Full Text] [Related]
12. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
Dudley MW
Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
[TBL] [Abstract][Full Text] [Related]
13. [Changes in regional cerebral catecholamines following middle cerebral artery occlusion in the rat].
Kaneko D; Nakamura N; Tamura A
No To Shinkei; 1985 Nov; 37(11):1079-85. PubMed ID: 4074579
[TBL] [Abstract][Full Text] [Related]
14. Effects of xylamine on vascular neuroeffector transmission.
Nedergaard OA; Cho AK; Waggaman LA
J Pharmacol Exp Ther; 1992 Jul; 262(1):231-7. PubMed ID: 1625202
[TBL] [Abstract][Full Text] [Related]
15. Chemical transformations of xylamine (N-2'-chloroethyl-N-ethyl-2-methylbenzylamine) in solution. Pharmacological activity of the species derived from this irreversible norepinephrine uptake inhibitor.
Ransom RW; Kammerer RC; Cho AK
Mol Pharmacol; 1982 Mar; 21(2):380-6. PubMed ID: 7099142
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of xylamine on the uptake of [3H]norepinephrine into primary astrocyte cultures.
Chang TK; Cheng JT
Brain Res; 1992 Nov; 597(1):162-5. PubMed ID: 1477731
[TBL] [Abstract][Full Text] [Related]
17. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
Feigenbaum J; Yanai J; Klawans H; Moon B
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
[TBL] [Abstract][Full Text] [Related]
18. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.
Cuadra G; Summers K; Giacobini E
J Pharmacol Exp Ther; 1994 Jul; 270(1):277-84. PubMed ID: 7913496
[TBL] [Abstract][Full Text] [Related]
20. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
Javitch JA; Blaustein RO; Snyder SH
Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
